Former Allscripts CEO lands $52M in startup funding

Listen
Text
  • Small
  • Medium
  • Large

Livongo, a Mountain View, Calif.-based diabetes management startup, raised an additional $52.5 million in funding, according to Chicago Inno.

Livongo — led by CEO Glen Tullman, former CEO of Allscripts — offers a blood glucose monitor, which connects to a digital dashboard for real-time health information. Its goal is to help diabetes patients manage their care.

This most recent funding round was co-led by General Catalyst and Kinnevik. Other investors included Singapore-based EDBI, American Investment Holdings and Microsoft Ventures.

The startup, which has raised more than $143 million since its launch in 2014, plans to expand into other chronic condition management services with this new funding. It will also begin distribution into international markets.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars